Login
$ACTU
$0.26 -$0.01 (2.99%) After hours

$ACTU SEC Filings

Filed On Filing
13 Nov 2026 FORM 10-Q SEP 2026
02 Nov 2026 Form 4: Thomson Todd S, Director and 6 others

Granted 344,755 Warrants (right to buy) · Granted 355,245 Warrants (right to buy)

30 Oct 2026 Form 4: Bios Fund III, Lp, Director and 2 others

Granted 3,000,000 Warrant (Right to Buy)

30 Oct 2026 SCHEDULE 13G
30 Oct 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing.

30 Oct 2026 Form 4: Bios Fund I, Lp, Director and 9 others

Granted 3,000,000 Warrant (Right to Buy)

29 Oct 2026 Form 4: Schmitt Daniel M, Director

Bought 140,844 shares ($50K) · Acquired 70,422 Warrant to Purchase Common Stock (Open Market Purchase)

28 Oct 2026 8-K: Entry into a Material Definitive Agreement; Other Events

The undersigned, Actuate Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Regis...

28 Oct 2026 FORM 424B5
26 Oct 2026 EFFECT
19 Oct 2026 FORM S-1 AMENDMENT
14 Oct 2026 FORM S-1 AMENDMENT
08 Oct 2026 FREE WRITING PROSPECTUS
06 Oct 2026 REGISTRATION STATEMENT
14 Aug 2026 Form 4: Schmitt Daniel M, Director

Received 272,056 shares by exercise or conversion · Gave up 120,521 shares to cover exercise price or tax ($122K)

14 Aug 2026 FORM 10-Q FOR JUN 2026
17 Jul 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

Notice of Delisting or Failure to Satisfy Continued Listing Rule or Standard; Transfer of Listing.

08 Jun 2026 DRS
22 May 2026 8-K: Submission of Matters to a Vote of Security Holders

On May 21, 2026, Actuate Therapeutics, Inc. (the “Company”) hosted its Annual Meeting of Stockholders (“Annual Meeting”) virtually. At the Annual Meeting, the Company's stockholders (i) elected each of the two Class II director nominees ...

22 May 2026 Form 4: Zabrowski Dan, Director

Granted 15,000 Stock Options

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support